Concepedia

Amy D. Guertin

AD

4

Publications

461

Citations

4

H-Index

2005

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Amy D. Guertin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and cancer biology.

Top concepts

Publications per year

2005–2016

4

Publications

4

Microanatomy of Axon/Glial Signaling during Wallerian Degeneration

Amy D. Guertin, Dan P. Zhang, Kimberley S. Mak et al. · Journal of Neuroscience · 2005 · 190 citations · Full text

Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy

Amy D. Guertin, Jing Li, Yaping Liu et al. · Molecular Cancer Therapeutics · 2013 · 169 citations

Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

Amy D. Guertin, Melissa M. Martin, Brian S. Roberts et al. · Cancer Cell International · 2012 · 82 citations · Full text

High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck et al. · Molecular Cancer Therapeutics · 2016 · 20 citations · Full text

, , +17

Rows per page

1–4 of 4